Last updated 14 days ago

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

480 patients around the world
Available in Puerto Rico, Chile, United States, Argentina
AbbVie
20Research sites
480Patients around the world
This study is for people with
Arthritis
Rheumatoid arthritis
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Instituto Médico de Alta Complejidad San Isidro IMACSI
Instituto Médico de Alta Complejidad San Isidro IMACSI
Av. del Libertador 16958, San Isidro, Buenos Aires
Consultorios Reumatológicos Pampa
Consultorios Reumatológicos Pampa
La Pampa 1548, CABA, Buenos Aires
Organización Médica de Investigación (OMI)
Recruiting
Uruguay 725 PB , Buenos Aires, CP: 1015
Instituto Médico Damic S.R.L.
Instituto Médico Damic S.R.L.
Av. Colón 2057, Córdoba
Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
Av. Luis Maria Campos 726, CABA, Buenos Aires
CEDIMBA - DIM Clínica Privada - Buenos Aires
CEDIMBA - DIM Clínica Privada - Buenos Aires
Belgrano 136, Ramos Mejia, Buenos Aires.
Centro Integral de Reumatología - Tucumán
Santiago del Estero 60, S. M. de Tucuman
Centro de Investigaciones Médicas Tucumán
Recruiting
Lavalle 506, T4000 San Miguel de Tucumán, Tucumán, Argentina
Hospital Italiano de La Plata
Av. 51 entre 29 y 30 Nro 1725, La Plata, Buenos Aires
Instituto CAICI - Rosario, Santa Fe
Mendoza 2612, Rosario, Santa Fe
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy